Anbio Biotechnology Limited

NNNN

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$5.00 1,600,000 Positive High 3.7%

Offering Team

Deal Managers

  • AC Sunshine Securities

Lawyers

  • Ortoli Rosenstadt LLP

Auditors

  • YCM CPA INC

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portf More

Deal Tracker

Investors

Filing

31 Dec, 2024

Offer

19 Feb, 2025

Look Ahead

Lock Up Expiry

19 Aug, 2025

Earning

Nov 1, 2018

IPO Terms

Offer Price $5.00
Offer Size 1M

Market Sentiments

Stock Price